Manager TitleAgeSince
Chief Operating Officer 67 2005-12-31
Chief Executive Officer 73 -
Chief Executive Officer 50 2023-12-28
Director TitleAgeSince
Chairman 73 2024-12-15
Director/Board Member 67 2005-12-31
Chairman - -
Change 5-day change 1-year change 3-year change Capi.($)
-12.13%-36.36% - - 1.4M
+4.16%+3.04%+49.37%+94.17% 74.16B
+0.66%-2.82%+20.74%+79.96% 57.39B
+0.62%-2.60%+2.12%+35.51% 47.64B
+0.36%+0.81%+342.39%+748.97% 44.29B
-0.96%-4.50%+24.96%+31.45% 42.5B
-0.20%-0.77%+4.13%+111.69% 40.71B
-0.54%+2.93%+9.31%+54.06% 30.97B
+1.56%+3.75%+31.90%+29.14% 28.53B
+0.05%-1.64%-8.14%-12.10% 24.34B
Average -0.64%-0.59%+52.98%+130.32% 43.39B
Weighted average by Cap. +0.95%-0.84%+57.22%+139.63%
Logo 2cureX AB
2cureX AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of diagnostic substances to select treatment for cancer patients. The Company's product candidate, IndiTreat - CRC, aims at optimizing medical treatment for the colorectal cancer patients. Through IndiTreat - CRC, healthcare professionals collect a tumor sample from patients to create a number of three-dimensional micro tumors in order to test available chemotherapies and experimental treatments. The Company's product pipeline includes also IndiTreat - OVA, targeting ovarian cancer treatment, and IndiTreat - KDN, focusing on kidney cancer treatment. It operates through 2cureX A/S.
Employees
14
  1. Stock Market
  2. Stocks
  3. 2CUREX Stock